Neogen (NEOG) EBIT Growth (5y) (2015 - 2026)
Neogen (NEOG) EBIT Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -17.18% |
| Nov 30, 2025 | -17.91% |
| Aug 31, 2025 | -52.34% |
| May 31, 2025 | -100.80% |
| Feb 28, 2025 | -16.17% |
| Nov 30, 2024 | -93.37% |
| Aug 31, 2024 | -32.63% |
| May 31, 2024 | -6.99% |
| Feb 29, 2024 | -3.86% |
| Nov 30, 2023 | -4.54% |
| Aug 31, 2023 | 3.03% |
| May 31, 2023 | 3.36% |
| Feb 28, 2023 | -0.29% |
| Nov 30, 2022 | -19.39% |
| Aug 31, 2022 | -18.07% |
| May 31, 2022 | -1.05% |
| Feb 28, 2022 | -14.97% |
| Nov 30, 2021 | -5.85% |
| Aug 31, 2021 | 8.08% |
| May 31, 2021 | 5.33% |